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Introduction: Left subclavian artery (LSA) coverage during thoracic endovascular aortic repair (TEVAR) is often
necessary due to anatomic factors and is performed in to up to 40% of procedures. Despite the frequency of LSA coverage
during TEVAR, reported associations with risk of periprocedural stroke or death are inconsistent in reported literature.
We examined the 2005-2008 American College of Surgeons National Surgical Quality Improvement Program Participant
Use Data file to determine associations between LSA coverage during TEVAR and risk of perioperative stroke or death.
Methods:Current procedural terminology (CPT) codes were used to identify patients undergoing TEVAR, LSA coverage,
and subclavian revascularization. Patients undergoing coronary bypass, ascending aortic repair, abdominal aortic
aneurysm repair, or nonvascular intra-abdominal procedures during the same operation were excluded. Perioperative
stroke and mortality associations with LSA coverage were examined using logistic regression models for each outcome.
Significance was assessed at   0.05, with univariable P < .05 required for multivariable model entry.
Results: Eight hundred forty-five TEVAR procedures were identified, of which 52 patients were excluded due to
additional major procedures performed with TEVAR. Seven hundred thirty-three of the remaining 793 procedures
included CPT codes indicating primary placement of an initial thoracic endograft and form the basis of this analysis. LSA
coverage occurred in 279 procedures (38%). Thirty-day stroke and mortality rates were 5.7% and 7.0%, respectively. LSA
coverage was associated with increased 30-day risk of stroke in multivariable modeling (odds ratio [OR], 2.17 95%
confidence interval [CI], 1.13-4.14; P  .019). Other significant multivariable risk factors for stroke included proximal
aortic cuff placement during TEVAR (OR, 2.58; 95% CI, 1.30-5.16; P  .007) and emergency procedure status (OR,
3.60; 95% CI, 1.87-6.94; P < .001). No significant association between LSA coverage and perioperative mortality was
identified (univariable OR, 1.70; 95% CI, 0.98-2.93; P  .0578).
Conclusion: LSA coverage during thoracic endovascular repair is associated with increased risk of perioperative stroke
following TEVAR. Further evidence is needed to determine whether procedural modifications, including LSA revascu-
larization, reduce the incidence of stroke associated with TEVAR. (J Vasc Surg 2011;54:979-84.)
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doi:10.1016/j.jvs.2011.03.270Thoracic endovascular aortic repair (TEVAR)has become
ncreasingly utilized for treatment of a variety of aortic pathol-
gies since the introduction of commercially available dev-
ces.1-3 Left subclavian artery (LSA) coverage during TEVAR
s often necessary due to anatomic factors and is performed in
o up to 40% of procedures.2,4 Despite the frequency of LSA
overage during TEVAR, reported associations with risk of
eriprocedural stroke or death are inconsistent in reported
iterature. Sample size limitations, heterogeneity in patient
election criteria, and individualized device utilization patterns
ake generalization of findings related to the clinical impact
f LSA coverage from single-center retrospective and industry-
ponsored prospective studies challenging. The role of left
ubclavian revascularization during TEVAR likewise remains
ontroversial. A2009 consensus statement from the Society of
ascular Surgery described quality of existing evidence to
uide performance of subclavian revascularization in patients
ndergoing TEVAR as “very low.”3 This same conclusion
as also reached by the authors of a recent meta-analysis
xamining morbidity and mortality effects of LSA coverage
uring TEVAR, who suggested that improvement of the
vidence base will require expansion of multicenter collabor-
tive efforts to obtain sufficient numbers of patients and events
ecessary for more powerful analyses.5
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October 2011980 Chung et alIn this context, we analyzed TEVAR procedures from
the American College of Surgeons National Surgical Qual-
ity Improvement Program (ACS-NSQIP) Participant Use
Data File to further characterize the influence of LSA
coverage on 30-day risk of stroke or death. The ACS-
NSQIP collects patient-level preoperative, procedural, and
postoperative data, including 30-day mortality and mor-
bidity outcomes; data are captured by surgical clinical re-
viewers at participating sites and entered into a Web-based
collection system.6 Surgical clinical reviewers receive formal
training, and inter-rater reliability audits are conducted
periodically for all sites to ensure data quality.
METHODS
Procedure identification and categorization. Current
Procedural Terminology (CPT) codes were used to identify
TEVAR procedures from the 2005-2008 ACS-NSQIP
Participant Use Datafile (Table I). The ACS-NSQIP col-
lects patient-level preoperative, procedural, and postoper-
ative data, including 30-day mortality and morbidity out-
comes. Data are captured by formally trained surgical
clinical reviewers at participating sites and entered into a
Web-based collection system, and inter-rater reliability au-
dits are conducted periodically for all sites to ensure data
quality.6 All available CPT code fields (maximum of 20
codes per procedure) were queried to identify both
TEVARs and any other procedures performed during the
same anesthetic, including subclavian artery revasculariza-
tion. CPTs 33880 or 33881 were considered indicators of
Table I. Procedure designation based on CPT codes
Procedure designation CPT codes
TEVAR 33880
33881
33883
33884
33886
Placement of initial thoracic aortic
endoprosthesisa 33880
33881
Left subclavian artery coverage during TEVAR 33880
Placement of proximal thoracic aortic extension
endoprosthesis 33883
33884
Placement of distal thoracic aortic extension
endoprosthesis 33886
Subclavian artery revascularization in combination
with TEVAR 33889
33891
33875
33877
Brachial artery exposure for delivery of
endoprosthesis 34834
Iliac artery exposure for delivery of endoprosthesis 34820
34833
TEVAR, Thoracic endovascular aortic repair.
All available code fields (n  21) were queried for each procedure.
aPlacement of initial thoracic aortic endoprosthesis required for inclusion in
mortality and stroke models.placement of an initial thoracic aortic endoprosthesis, and iPT 33880 was used as an indicator of LSA coverage.
ostoperative diagnoses were categorized as aneurysm, dis-
ection, or other using the “PODIAG” variable, indicating
he postoperative diagnosis based on the appropriate Inter-
ational Classification of Diseases, Ninth Revision-Clinical
odification (ICD-9-CM) code designated as correspond-
ng to the operative report and/or pathology results.
Patients undergoing simultaneous coronary artery bypass,
scending aortic repair, abdominal aortic aneurysm repair, or
ther major nonvascular procedures not routinely performed
n conjunction with TEVAR were excluded from analysis.
rocedures involving placement of proximal and/or distal
xtension endoprostheses without placement of an initial en-
oprosthesis were included in descriptive analyses; these pro-
edures were not included in models of perioperative mortal-
ty or stroke, however, because we could not discern whether
hey resulted in coverage of the LSA.
Data analysis. Descriptive statistics are reported as
ean standard deviation for continuous variables and num-
er (%) for categorical variables. Group-wise comparisons
ere performed using 2 or Fisher’s exact test for categorical
ariables and t tests for continuous variables depending on
ata distributions; when appropriate, continuous variables
ere log-transformed prior to group-wise comparisons to
atisfy normality assumptions. Significancewas assessed at an
evel of 0.05, and adjustment for multiple group-wise com-
arisons of preoperative and procedural factors was performed
sing the Bonferroni method.
Associations between LSA coverage during TEVAR
nd 30-day risk of stroke and mortality were examined
sing uni- and multivariable logistic regression. Preopera-
ive laboratory variables that were 10% incomplete were
xcluded from consideration as candidate covariates. Mul-
ivariable models were constructed using a forward selec-
ion approach with P .05 required for model entry. Odds
atios are expressed per standard deviation change for con-
inuous covariates. All statistical analyses were performed
ith SAS version 9.2 (SAS Institute, Cary, NC).
ESULTS
Patient and procedural characteristics. Eight hun-
red forty-five TEVAR procedures were identified, of
hich 52 were excluded from analysis due to additional
ajor procedures performed during the same anesthetic,
ncluding: abdominal aortic aneurysm repair (n  47),
owel resection (n 4), coronary bypass (n 2), splenec-
omy (n  1), and ascending aortic repair (n  1). Seven
undred thirty-three of the remaining 793 TEVAR proce-
ures included placement of an initial thoracic endograft,
hile 60 involved placement of a proximal and/or distal
xtension prosthesis without a code indicating placement
f an initial thoracic endograft during the same procedure.
single perioperative mortality and no perioperative
trokes were observed in this latter group of procedures
nvolving placement extension prostheses in a separate pro-
edure from primary endograft placement, which were not
ncluded in stroke and mortality models.
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Volume 54, Number 4 Chung et al 981Among TEVARs with CPT codes indicating placement
of an initial thoracic endoprosthesis, postoperative diagno-
sis was identified as aneurysm in 74% of patients undergo-
ing TEVAR, while 22% had ICD-9-CM codes indicating
dissection pathology. TEVAR procedures consisted of a
single thoracic endograft placement in 82.3% of proce-
dures, while the remaining 17.7% also had codes indicating
placement of proximal aortic cuffs during the same proce-
dure. CPT codes indicating LSA coverage were identified
for 279/733 procedures (38.1%), and 28 patients with
LSA coverage (3.8%) had subclavian revascularization per-
formed during the same anesthetic as TEVAR. Preopera-
tive demographic, comorbidity, laboratory, and procedural
data categorized by LSA coverage status are summarized in
Table II. Preoperative and procedural factors were gener-
ally similar between groups. Patients undergoing LSA cov-
erage during TEVAR had higher rates of preoperative
ventilator dependence (7.5% vs 3.5%), emergent procedure
Table II. Comparison of preoperative and procedural cha
Variable
Demographic/anthropometric factors
Age 80
Male
Body mass index 2
Medical history
Hypertension
Current smoker
Chronic obstructive pulmonary disease
Diabetes
Stroke
Myocardial infarctiona
Angina
Preoperative hemodialysis
Congestive heart failureb
Dependent functional status
Acute preoperative conditions
Renal failure
Sepsis
Pneumonia
Ventilator-dependent
Preoperative laboratory data
Serum creatinine (mg/dL)
Hematocrit (%) 3
White blood cell count (1000/mL3)
Procedural characteristics
Emergent procedure
Aortic dissection (vs other diagnosis)
General anesthesia
Brachial and/or iliac access
Units packed red blood cells transfused
Operation time (minutes) 16
Proximal aortic cuff placement
P  .002 required for significance at   0.05 after adjusting for multiple t
aWithin 6 months prior to procedure.
bWithin 30 days prior to procedure.
cFisher’s exact test.
dNonparametric (Wilcoxon) method.status (22.2% vs 15%), and postoperative diagnoses indicat- rng dissection pathology (25.5% vs 19.1%). Patients under-
oing LSA coverage during TEVAR also had lower rates of
PT codes indicating iliac or brachial access for endograft
elivery (8.2% vs 15.2%). These group-wise differences
ased on LSA coverage status were not significant, how-
ver, after adjustment for multiple testing.
Perioperative stroke. Forty-two strokes occurred
ithin 30 days of TEVAR for an overall perioperative
troke rate of 5.7%. The median time interval between
EVAR and diagnosis of stroke was 2 days, and 75% of
erioperative strokes were diagnosed within 7 days. Among
atients undergoing LSA coverage, 24/279 (8.6%) had
erioperative strokes vs 18/454 (4.0%) patients without
SA coverage during TEVAR. No association was identi-
ed between past medical history of stroke and risk for
erioperative stroke following TEVAR (univariable odds
atio [OR], 1.35; 95% confidence interval [CI], 0.55-
.31). LSA coverage was associated with increased 30-day
ristics based on left subclavian artery coverage status
eft subclavian artery coverage
o
454)
Yes
(n  279) P
.0% 20.4% .260
.9% 59.9% .607
6.0 27.7  6.0 .052
.5% 86.7% .467
.8% 35.8% .402
.8% 17.9% .525
.2% 13.6% .337
.0% 11.5% .849
.2% 0.7% .146c
.7% 5.4% .294
.1% 5.4% .122
.5% 3.2% .130
.7% 16.9% .239
.3% 1.8% .611
.6% 4.7% .145
.8% 2.2% .709
.5% 7.5% .016
0.6 1.1  0.5 .365
5.6 36.0  6.4 .678
3.8 9.3  4.8 .145d
.0% 22.2% .013
.1% 25.5% .045
.2% 90.0% .579
.2% 8.2% .006
1.9 1.1  2.4 .628d
103.1 173.6  100.8 .219
.7% 15.4% .252
(Bonferroni method).racte
L
N
(n 
24
57
6.8 
88
32
19
11
11
2
3
3
1
13
1
2
1
3
1.1 
6.2 
8.6 
15
19
91
15
0.8 
5.7 
18
estingisk of stroke in univariable analysis (OR, 2.28; 95% CI,
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October 2011982 Chung et al1.21-4.28; P .010) and remained a significant risk factor
in multivariable modeling (OR, 2.17; 95% CI, 1.13-4.14;
P  .019). Other significant multivariable risk factors for
stroke included proximal aortic cuff placement during
TEVAR (OR, 2.58; 95% CI, 1.30-5.16; P  .007) and
emergency procedure status (OR, 3.60; 95% CI, 1.87-
6.94; P  .001; Table III).
Perioperative mortality. Fifty-six deaths occurred
within 30 days of TEVAR for an overall perioperative
mortality rate of 7.0%. Thirty-day mortality occurred in
28/279 patients (10%) with LSA coverage vs 28/454
patients (6.2%) without LSA coverage during TEVAR.
Univariable analyses of 30-day mortality showed highly
significant associations between 30-day mortality and a
number of risk factors (Table IV), including: use of brachial
and/or iliac artery exposure for device delivery (OR, 2.56;
95% CI, 1.34-2.50; P  .0045), preoperative ventilator
dependence (OR, 7.11; 95% CI, 3.35-15.10; P  .0001),
Table III. Associations with 30-day stroke risk following
Risk factor
Uni
Odds ratio
(95% confidence in
Left subclavian artery coverage 2.28 (1.21-4.2
Left subclavian artery revascularization 3.32 (1.21-9.1
Emergent procedure 3.97 (2.09-7.5
Proximal aortic cuff placement 2.53 (1.29-4.9
White blood cell count (1000/mL3) 1.34 (1.08-1.6
Units packed red blood cells transfused 1.12 (1.01-1.2
Displayed covariates represent those with univariable P  .05 used as criter
Table IV. Associations with 30-day mortality risk
following TEVAR
Covariate
Univariable
Odds ratio
(95% confidence interval) P
Left subclavian artery
coverage 1.70 (0.98-2.93) .0578
Units packed red blood cells
transfused 1.35 (1.24-1.48) .0001
White blood cell count
(1000/mL3) 1.67 (1.36-2.05) .0001
Preoperative serum
creatinine (mg/dL) 1.40 (1.07-1.83) .0135
Emergent procedure 4.39 (2.49-7.74) .0001
Brachial or iliac access 2.56 (1.34-4.90) .0045
Preoperative sepsis 6.47 (2.66-15.76) .0001
Preoperative acute renal
failure 4.74 (1.22-18.38) .0245
Preoperative ventilator
dependence 7.11 (3.35-15.10) .0001
Operative time (minutes) 1.67 (1.28-2.18) .0002
TEVAR, Thoracic endovascular aortic repair.
Covariates displayed in addition to left subclavian artery coverage represent
those with univariable P  .05 used as criterion for multivariable model
entry.units of blood transfused intraoperatively (OR, 1.35; 95% sI, 1.24-1.48; P  .0001), preoperative white blood cell
ount (OR, 1.67; 95% CI, 1.35-2.05; P  .0001), preop-
rative sepsis (OR, 6.47; 95% CI, 2.66-15.76; P .0001),
og-transformed operative time in minutes (OR, 1.67; 95%
I, 1.28-2.18; P .0002), and emergent procedure status
OR, 4.39; 95% CI, 2.49-7.74; P  .0001). The increased
ortality rate in patients undergoing LSA coverage was not
ignificant in univariable modeling (OR, 1.70; 95% CI,
.98-2.93; P .058; Table IV). Because LSA coverage did
ot meet the significance criterion for multivariable mor-
ality model inclusion and the intent of our analysis was to
valuate associations between LSA coverage and clinical
utcomes, mortality analyses were therefore limited to uni-
ariable models.
ISCUSSION
Since the initial description of TEVAR by Dake and
olleagues,7 introduction of commercially available devices
as been followed by expanding use for management of
horacic aortic pathology has stimulated interest in the
nfluence of left LSA coverage on perioperative outcomes.
n our analysis of TEVAR procedures within the ACS-
SQIP Participant Use Datafile, 30-day stroke and mor-
ality rates among patients undergoing primary TEVAR
ere 5.7% and 7.0%. respectively. Left subclavian artery
overage was associated with increased 30-day stroke risk
mong patients undergoing primary TEVAR in our multi-
ariable model accounting for other predictive risk factors,
ut no significant association between LSA coverage and
erioperative mortality was observed. Other independent
isk factors for stroke were emergent procedure status and
roximal aortic cuff placement. All perioperative strokes
nd 98% of perioperative mortalities were observed in pa-
ients undergoing primary TEVAR, while these adverse
vents were much less frequent following proximal and/or
istal extension prostheses placement performed as a sepa-
ate procedure from the initial thoracic endograft proce-
ure.
Lower 30-day stroke and mortality rates than those
bserved in this analysis have been reported from recent
rospective, industry-sponsored US trials evaluating
EVAR with specific devices (2%-4% and 1%-2%, respec-
ively).8-10 Because clinical trials are often defined by a
cic endovascular aortic repair
ble Multivariable
l) P
Odds ratio
(95% confidence interval) P
.010 2.17 (1.13-4.14) .019
.020 — —
.001 3.60 (1.87-6.94) .001
.007 2.58 (1.30-5.16) .007
.010 — —
.033 — —
consideration for entry into multivariable model using forward selection.thora
varia
terva
8)
3)
3)
6)
8)
4)ingle aortic pathology, uniformly include anatomic enroll-
l
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and predominantly enroll from high-volume centers of
excellence, rates of LSA coverage and adverse events within
trials likely differ from clinical practice outside of study
protocols. TEVARs analyzed in this study were performed
at multiple centers for a variety of pathologies using heter-
ogeneous patient selection criteria; perioperative adverse
event rates associated with these procedures therefore may
be more representative of outcomes associated with
broader clinical application commercially available devices.
Contemporary single-center retrospective analyses of
TEVAR outcomes reported perioperative stroke and mor-
tality rates of 3% to 10% and 0% to 10%, respect-
ively,2,4,11-17 are comparable with the rates we observed
and likely also reflect influences of broader patient selection
criteria and a wider range of clinician experience.
Several prior authors have attempted to ascertain the
etiology of perioperative stroke after TEVAR and found
similar determinants as were described in our analysis. For
instance, associations between proximal extent of aortic
coverage during TEVAR and perioperative stroke risk were
reported by Feezor et al in their single-center analysis as
well as Fairman et al from the Medtronic Vascular Talent
Thoracic Stent Graft System for the Treatment of Thoracic
Aneurysms (VALOR) Trial.8 Other authors also identified
LSA coverage as a risk factor for perioperative stroke5,18
Moreover, prior studies failed to clearly identify whether
LSA revascularization protected patients from stroke. Coo-
per et al identified a higher incidence of stroke in patients
undergoing LSA coverage, including both patients treated
with preoperative subclavian revascularization (pooled OR,
3.18; 95% CI, 1.17-8.65) and patients managed with LSA
coverage alone (pooled OR, 2.28; 95% CI, 1.28-4.09).
The association we observed between perioperative stroke
and emergent procedure status in multivariable modeling is
consistent with the findings of Cambria and colleagues,
who observed a 15.3% incidence of perioperative stroke
associated with TEVAR performed for acute catastrophes
of the thoracic aorta.19
Reported rates of subclavian revascularization in the set-
ting of TEVAR-related coverage are 15% to 25%, with the
majority of revascularizations performed as a separate proce-
dure prior to anticipated coverage during TEVAR.2,8,11 Al-
though associations between LSA coverage and periopera-
tive adverse neurologic events have been identified in this
study and others, it is not clear that routine revasculariza-
tion would result in a reduction in perioperative stroke
complications. We identified a univariable association be-
tween simultaneous LSA revascularization and increased
30-day stroke risk, but this association was not significant in
multivariable modeling; these observations resemble those
of Kotelis et al, who noted lower stroke rates in the setting
of LSA coverage without versus with revascularization.2
Image-based evaluations of post-TEVAR neurologic com-
plications have revealed anterior circulation stroke distribu-
tions in a significant proportion of patients4,13,17; these
anterior infarcts are presumably embolic in nature and
therefore not necessarily avoided by pre-emptive revascu- earization. These inferences are supported by the findings of
ooper et al, who concluded that pre-emptive subclavian
evascularization offers no protection against stroke associ-
ted with TEVAR.18 Riesenman and colleagues observed
artial LSA coverage in 10 out of 24 patients with preser-
ation of antegrade subclavian flow following TEVAR,14
emonstrating that identification of LSA coverage based on
PT codes and/or operative reports should not be consid-
red uniformly consistent with endograft-induced subcla-
ian artery occlusion. We observed a low rate of subclavian
evascularization performed at the time of TEVAR in the
urrent study and did not detect any association between
imultaneous revascularization and stroke or mortality risk
mong patients with LSA coverage. However, the ACS-
SQIP data file lacks sufficient detail regarding vertebral
rtery anatomy and location of the proximal landing zone,
imiting our ability to determine whether strokes occurred
ecause of increased manipulation within the arch, or
hether the strokes occurred due to ischemia secondary to
eft subclavian artery coverage. Furthermore, we were only
ble to identify LSA revascularizations associated with
EVAR in the ACS-NSQIP datafile if both procedures
ere performed during the same anesthetic. Several series
ave reported performance of LSA revascularization as a
eparate procedure done prior to TEVAR in the majority of
atients,2,9,12 so it is probable that an unknown number of
he TEVAR procedures we analyzed were performed on
atients who underwent an initial LSA revascularization
hat could not be identified. The true incidence of LSA
evascularization within this series is therefore unknown,
eaving us unable to conduct a valid analysis of the effects of
evascularization on stroke risk.
Although we observed a higher perioperative mortality
ate in patients undergoing LSA coverage during TEVAR
10% vs 6.2%), this difference did not meet the significance
riterion selected for multivariable model inclusion. De-
pite the relative sample size advantage of our analysis over
ome of the largest previously published studies, evaluating
he impact of LSA coverage on TEVAR outcomes, low
vent rates limited our ability to conduct robust multivari-
ble analyses.20 These power limitations related to assess-
ent of TEVAR outcomes have been described previously5
nd further illustrate the need for future multicenter col-
aborative efforts to expand existing evidence. Given the
ncreasing number of studies demonstrating associations
etween LSA coverage and adverse events (including spinal
ord injury and upper extremity ischemia in addition to
troke), randomized evaluations of LSA revascularization
ay be difficult to conduct, and meaningful expansion of
xisting evidence therefore will likely depend on compara-
ive effectiveness studies.
Several other limitations of this analysis deserve specific
ention. First, the ACS-NSQIP was not specifically de-
igned for analysis of TEVAR outcomes and therefore lacks
reoperative anatomic variables (such as vertebral artery
natomy) and additional postoperative outcomes relevant
o LSA coverage (such as spinal cord injury and upper
xtremity ischemia). Second, because patients with acute
11
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findings cannot be generalized to TEVAR procedures per-
formed for traumatic aortic injury. Also, because trauma
cases are specifically excluded from ACS-NSQIP, our find-
ings cannot be generalized to TEVAR procedures per-
formed for traumatic aortic injury. Finally, the coding-
based methods for identification of cases and diagnoses
utilized for this analysis are subject to potential errors
related to misclassification, although the potential for this
type of bias may be lowered by the standardized data
collection training and reliability audits conducted by ACS-
NSQIP. Despite these limitations, the number of TEVAR
procedures included in this analysis compares favorably
with some of the largest series published to date2,10,11,21
and validates the association between LSA coverage and
risk of perioperative stroke reported by others. Stroke and
mortality rates from this analysis also provide an informa-
tive comparison between outcomes of contemporary clini-
cal practice and published results of clinical trials.
CONCLUSION
Left subclavian artery coverage during thoracic endo-
vascular repair is associated with increased risk of perioper-
ative stroke; other observed risk factors for perioperative
stroke include proximal aortic cuff placement and emergent
procedure status. Additional evidence is needed to eluci-
date the mechanism of stroke during TEVAR and ulti-
mately help prevent this devastating adverse event. Due to
low event rates and the rapid evolution of thoracic en-
dograft technology, multicenter collaborative efforts fo-
cused on TEVAR-specific endpoints will be critical for
overcoming power limitations of existing evidence.
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